STRS Ohio’s Zentalis Pharmaceuticals ZNTL Stock Holding History

STRS Ohio’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,000	Closed	-$924K	–	2252
2021 Q4	$924K	Buy	11,000 +5,700	+108%	+$441K	﹤0.01%	1169
2021 Q3	$353K	Buy	5,300 +1,500	+39%	+$86.5K	﹤0.01%	1618
2021 Q2	$202K	Buy	3,800 +400	+12%	+$21.4K	﹤0.01%	1814
2021 Q1	$147K	Hold	3,400	–	–	﹤0.01%	1861
2020 Q4	$176K	Buy	3,400 +700	+26%	+$31.6K	﹤0.01%	1769
2020 Q3	$88K	Hold	2,700	–	–	﹤0.01%	1867
2020 Q2	$129K	Buy	+2,700	New	+$104K	﹤0.01%	1737

Other funds holding ZNTL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

STRS Ohio's ZNTL Position: Q1 2022 in Review

STRS Ohio sold out of Zentalis Pharmaceuticals (ZNTL) in Q1 2022, closing a stake of 11,000 shares — an estimated $924K sold.

STRS Ohio first reported a position in ZNTL in Q2 2020 and held it in 7 quarters. The position peaked at $924K in Q4 2021. 128 funds tracked by Wall St. Rank hold ZNTL as of Q1 2022.

STRS Ohio reported no remaining Zentalis Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
STRS Ohio sold 11,000 Zentalis Pharmaceuticals shares in Q1 2022, an estimated $924K.
STRS Ohio first reported a position in Zentalis Pharmaceuticals in Q2 2020 and held it in 7 quarters.
STRS Ohio's Zentalis Pharmaceuticals position peaked at $924K in Q4 2021.
128 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2022.

Based on STRS Ohio's 13F filing for Q1 2022, filed 21 Apr 2022.